Independence
Reviewers are always independent of the content's author — no co-authorship or institutional conflicts permitted.
Evidence-First
Every factual claim verified against peer-reviewed literature before any article is approved.
Currency
Information must reflect current clinical guidelines and active clinical practice — not outdated standards.
Completeness
No significant clinical omissions that could affect reader safety or lead to incorrect decisions.
Balance
Competing evidence presented fairly without commercial bias or undue prominence of any treatment.
Safety
Adequate warnings, contraindications, red flags, and emergency guidance always included where relevant.
Compassion
Patient-facing content reviewed for tone, sensitivity, accessibility, and safe messaging compliance.
Continuity
Review is not a one-time event — all content is monitored, scheduled for re-review, and updated.
- ❌ A rubber stamp — reviewers genuinely challenge, query, and revise content
- ❌ A commercial endorsement — reviewer credit does not imply personal product recommendation
- ❌ A substitute for clinical consultation — all reviewed content remains educational only
- ❌ Permanent — all reviewed content has an expiry date and is scheduled for re-review
Tier 1 — Specialty Medical Reviewers
- Board-certified or fellowship-trained specialists
- Active clinical practice in stated specialty
- Minimum 5 years post-qualification experience
- Review articles only within their specific area of expertise
- Examples: Cardiologist reviewing cardiology; Neurosurgeon reviewing neurosurgery
Tier 2 — General Medical Reviewers
- Licensed physicians with broad clinical experience
- Minimum MBBS/MD plus 7 years clinical experience
- Review general medicine, primary care, and wellness content
- Refer specialty content upward to Tier 1 reviewers
Tier 3 — Allied Health Reviewers
- Registered nurses, pharmacists, physiotherapists, dietitians, psychologists
- Licensed and actively practicing in their field
- Review content within their specific professional scope only
- All allied health reviewed content also undergoes physician sign-off
Our reviewer network spans multiple countries and healthcare systems, ensuring content reflects diverse clinical contexts. Regional variations in guidelines and practice are noted in articles where relevant.
- Medical degree (MBBS, MD, DO, MBChB, or equivalent) from accredited institution
- Postgraduate specialist qualification: MRCP / FRCP / FRCS (UK) · FCPS / MCPS (Pakistan) · Board Certification (USA) · FRACP / FRACS (Australia) · DM / MS / MCh (India) · or equivalent
- Active, unrestricted medical license in country of practice
- No current or pending disciplinary proceedings
- Minimum 5 years post-specialist qualification clinical experience
- Currently seeing patients in clinical practice
- Affiliated with a recognised hospital, clinic, or academic institution
- Maintains continuing medical education (CME) requirements for their specialty
- Up to date with current clinical guidelines in their specialty area
- Completes DrInsight Reviewer Orientation Program
- Signs Medical Reviewer Agreement before first review
- Submits full Conflict of Interest Disclosure
- Annual licensure re-verification
- Minimum 4 reviews per year to maintain active reviewer status
- Immediate notification if licensure status changes
Phase 1
Pre-Review Preparation
Phase 2
Active Medical Review
Phase 3
Decision & Resolution
Phase 4
Publication & Beyond
📥 Content Submission
- Draft must meet minimum word count and source requirements
- Specialty tag determines which reviewer tier is assigned
🖊️ Editorial Pre-Screen
- ✅ Article structure complete and logical
- ✅ Minimum 5 peer-reviewed sources included
- ✅ Plain language standards met (patient-facing content)
- ✅ Author COI disclosure submitted
- ✅ Safe messaging guidelines followed (if applicable)
- Articles failing pre-screen returned to author with specific written feedback
👨⚕️ Reviewer Assignment
🔬 Clinical Accuracy Review
🛡️ Completeness & Safety Review
- All significant contraindications listed?
- Red flag symptoms clearly identified?
- Drug interactions and side effects adequately covered?
- Appropriate "when to seek medical care" guidance?
- Vulnerable populations addressed? (pregnancy, pediatrics, elderly, renal/hepatic impairment)
⚖️ Balance & Bias Review
💛 Tone & Accessibility Review
✅ APPROVED
- Content meets all clinical standards
- Reviewer submits signed approval with review date
- Reviewer credit added to article
- Article advances to final editorial sign-off
🔄 REVISIONS NEEDED
- Specific changes required before approval
- Detailed revision notes returned to author
- Author has 5 business days to revise and resubmit
- Revised article returns to same reviewer
- Maximum 2 revision cycles before escalation to Editorial Board
❌ REJECTED
- Fundamental clinical errors or unsafe content
- Editorial Board notified immediately
- Author may appeal within 10 business days
- If upheld: article not published
- If overturned: independent second opinion assigned
✅ Fact-Check Verification
📌 Final Editorial Sign-Off
🚀 Publication with Full Transparency
🔄 Post-Publication Monitoring
| Review Area | What Is Checked |
|---|---|
| Clinical Accuracy | All facts verified correct against current peer-reviewed evidence |
| Source Quality | Peer-reviewed, credible, not retracted, correctly interpreted |
| Currency | Information reflects current guidelines and clinical practice |
| Completeness | No significant clinical omissions that could affect safety |
| Safety | Adequate warnings, contraindications, and safety guidance included |
| Red Flags | Emergency symptoms clearly identified and appropriately emphasised |
| Drug Information | Names, doses, interactions, and indications verified against current formularies |
| Diagnostic Criteria | Matches current DSM-5, ICD-11, and specialty classification systems |
| Balance | Competing evidence presented fairly without undue prominence |
| Bias | No commercial or personal bias detectable in framing or emphasis |
| Tone | Compassionate, appropriate, non-alarming while remaining accurate |
| Readability | Appropriate plain language for stated target audience |
| Inclusivity | Diverse populations (age, gender, ethnicity, comorbidities) considered |
| Disclaimer | Medical disclaimer appropriately placed and clearly visible |
| References | All sources correctly cited, accessible, and within age guidelines |
- Reviewed by neurologist or neurosurgeon with subspecialty match
- Diagnostic criteria verified against current DSM-5 / ICD-11 / international neurology society guidelines
- Epilepsy, stroke, and movement disorder content requires subspecialist review
- Neuroimaging descriptions reviewed for accuracy and appropriate clinical caveats
- Reviewed by cardiologist or cardiothoracic surgeon
- Drug information verified against current ESC, AHA/ACC, and local formulary guidelines
- Cardiac emergency content reviewed for appropriate urgency framing
- Anticoagulation and antiarrhythmic content requires consultant-level cardiologist review
- Reviewed by board-certified paediatrician
- All dosing information confirmed as weight-based and age-stratified
- Developmental milestones verified against WHO and AAP standards
- Vaccine content verified against WHO EPI schedule and local national immunisation programme
- No content contradicting established vaccine safety evidence is published
- Reviewed by psychiatrist or clinical psychologist
- Safe messaging guidelines compliance confirmed by reviewer
- Crisis resource inclusion verified in all relevant articles
- Stigma-free, person-first language confirmed throughout
- Medication information verified against current prescribing guidelines
- Reviewed by oncologist with tumour-type subspecialty match where possible
- Staging information verified against current AJCC / TNM classification
- Treatment protocols verified against current NCCN, ESMO, or equivalent guidelines
- Survival statistics sourced from population-level data with appropriate caveats
- Clinical trial references clearly labelled as experimental
- Reviewed by clinical pharmacologist or specialist physician
- All drug information cross-referenced with BNF (British National Formulary), FDA prescribing information, and local national formulary
- Off-label use clearly labelled throughout
- Black box warnings prominently displayed
- Reviewed by surgeon with matching specialty certification
- Surgical indications and contraindications verified against current guidelines
- Complication rates sourced from peer-reviewed literature
- Recovery and outcome data presented as population averages with appropriate caveats
- Reviewed by radiologist or pathologist respectively
- Imaging descriptions reviewed for educational accuracy with appropriate disclaimers
- Laboratory reference ranges verified and clearly labelled as population norms
- Imaging examples confirmed as licensed or AI-generated — never real patient data without consent
We follow a strict evidence hierarchy when evaluating sources. All clinical claims must be supported by the highest available tier of evidence.
🥇 Systematic Reviews & Meta-Analyses
Highest Quality — Required for all clinical claims🥈 Randomised Controlled Trials (RCTs)
Gold standard for treatment efficacy🥉 Cohort & Case-Control Studies
Accepted with Tier 1 support📋 Expert Consensus & Clinical Guidelines
WHO, CDC, NHS, AHA, ADA, ESC, NICE, and equivalents📄 Case Reports & Expert Opinion
Supporting evidence only — never standalone for clinical claims- Minimum 5 peer-reviewed sources per clinical article
- Minimum 8 peer-reviewed sources per professional reference article
- Minimum 3 peer-reviewed sources per wellness or general health article
- Maximum source age: 10 years (landmark studies excepted)
- Preferred source age: within 5 years
- All sources linked to PubMed DOI or official guideline URL
- Wikipedia or user-edited content
- Non-peer-reviewed health blogs or websites
- Pharmaceutical promotional materials
- Unverified preprints (labelled "emerging research" only if referenced)
- Retracted studies
- AI-generated content presented as research evidence
Every article on DrInsight displays a review badge that indicates its current review status. Here is what each badge means.
Displayed on every reviewed article. Confirms full review by a qualified specialist. Links to reviewer's full bio page.
Displayed when scheduled re-review is in progress. Shows previous review date so readers can assess currency of information.
Displayed when content has passed its scheduled review date. Encourages readers to cross-reference with current guidelines. Triggers priority review assignment.
Displayed on professional-level clinical reference articles. Indicates subspecialty-level review. Highest tier of review credibility on the platform.
Displayed transparently on corrected articles. Shows what was corrected and why. Full correction log maintained in article footer.
| Content Type | Standard Review Cycle | Triggered Early If |
|---|---|---|
| Drug & Medication Guides | Every 6 months | Drug label change, recall, or safety warning |
| Clinical Overview Articles | Every 12 months | New major guideline published |
| Professional Reference Articles | Every 12 months | Significant new RCT or guideline |
| Surgical Procedure Articles | Every 12 months | New technique or safety data |
| Oncology Content | Every 6 months | New trial results or protocol update |
| Mental Health Articles | Every 12 months | New DSM/ICD update or guideline |
| Pediatric Content | Every 12 months | New AAP/WHO guideline published |
| Research Explainers | Every 24 months | Study retracted or superseded |
| Health & Wellness | Every 18 months | Significant new evidence emerges |
| Symptom Guides | Every 12 months | New diagnostic criteria published |
- Editorial calendar tracks all review due dates across the entire content library
- Managing Editor assigns re-review 30 days before due date
- Same reviewer invited to re-review where possible for continuity
- If original reviewer unavailable, new Tier 1 reviewer assigned
- Re-review follows identical process to initial review
- Updated review date and reviewer credit added on approval
- Reviewer requests specific factual corrections or source updates
- Author revises within 5 business days
- Re-review by same reviewer
- Article not published until corrections confirmed
- If already published: correction applied within 48 hours, correction notice added
- Multiple inaccuracies or significant omissions identified
- Article returned to author for substantial revision
- Editorial Board notified immediately
- If published: article temporarily unpublished pending correction
- ⚠️ Amber banner displayed at original URL during review
- Revised article requires full re-review before republication
- Content that could directly harm readers — immediately unpublished
- Editorial Board emergency meeting convened
- Author formally notified with full explanation
- Retraction notice published at original URL permanently
- Reason for retraction stated transparently
- Registered users who bookmarked the article notified by email
- Author's publishing privileges reviewed
- Content Review Calendar — Every article tracked with next review due date
- Guidelines Alert System — Editorial team subscribed to alerts from WHO, CDC, NHS, AHA, ESC, ADA, AAP, NICE, SIGN, and 40+ major medical societies
- PubMed Alerts — New publication alerts by specialty keyword
- Drug Safety Alerts — FDA and MHRA drug safety communications and recall notifications
- 👍/👎 ratings reviewed weekly by editorial team
- "Report an error" submissions reviewed within 5 business days
- Comments reviewed daily — clinical concerns escalated to reviewer within 24 hours
- All external reports acknowledged within 2 business days
- Reviewers are encouraged to proactively flag articles they have reviewed when significant new evidence emerges
- Reviewer-initiated urgent reviews processed within 48 hours
- Annual reviewer survey to identify content areas requiring priority re-review
| Correction Type | Response Time | Public Notice |
|---|---|---|
| Typographical error | 24 hours | Not required |
| Minor factual error | 5 business days | Correction notice on article |
| Significant clinical error | 48 hours | Prominent correction banner |
| Safety-critical error | Immediate unpublish | Urgent banner + email to bookmarkers |
| Full retraction | Within 24 hours of decision | Permanent retraction notice at URL |
- All corrections logged permanently in article footer
- Correction notices never silently removed
- Retraction notices remain permanently at original URL
- Annual corrections report published publicly by Editorial Board
- 📧 To report a correction: corrections@drinsight.org
- Reviewer must be institutionally independent of the article's author
- Reviewer must have no personal or financial relationship with the article's author
- Reviewer must have no commercial relationship with the article's subject matter that is undisclosed
- Financial relationships with pharmaceutical or device companies
- Funded research related to article topic
- Speaker fees or honoraria from companies related to article topic
- Stock ownership in relevant healthcare companies
- Employment or consultancy relationships
- Personal relationships with article author
- Minor disclosed COI: Reviewer proceeds with disclosure published on article
- Moderate COI: Second independent reviewer assigned for additional oversight
- Significant COI: Reviewer recused; new reviewer assigned
- All COI disclosures published on every reviewed article AND on reviewer bio page
- COI disclosures updated annually by all reviewers
- Reviewers must flag any article that appears to be primarily AI-generated without author disclosure
- AI-assisted content that has not been substantially rewritten by the human author should be rejected outright
- If AI use is disclosed by the author, reviewers must apply extra scrutiny to factual accuracy and source verification
- Reviewers may not use AI toolsto write or conduct their review — the review must reflect the reviewer's own independent clinical judgment
Currently 5 verified medical reviewers across 5 specialties — independently verified by our editorial team before every engagement.
Dr. James Okafor
NYU Langone Medical Center
MBBS, MD, MRCP
Specialises in migraine, neuro-oncology, and movement disorders
NeurologyDr. Sarah Mitchell
King's College Hospital
MBBS, MD, MRCP
Specialises in arrhythmia, cardiac imaging, and preventive cardiology
CardiologyDr. Priya Sharma
AIIMS New Delhi
MBBS, MD, FRCP
Specialises in diabetes, thyroid disorders, and obesity medicine
EndocrinologyDr. Emily Chen
Stanford Medicine
MD, Board Certified
Specialises in mood disorders, women's mental health, and CBT
PsychiatryDr. Carlos Rivera
Children's Hospital Los Angeles
MD, Board Certified
Specialises in paediatric infectious disease, vaccines, and neonatology
Pediatrics✍️ Join Our Medical Review Network
We are looking for specialist physicians, allied health professionals, and clinical academics who are passionate about combating medical misinformation and contributing to public health education.
🚨 Urgent Safety Concern
urgent@drinsight.orgContent posing immediate risk · Response within 4 hours during business hours
📍 Mailing Address
DrInsight Inc.
Badin
Pakistan
📘 Author Guidelines
View Author GuidelinesSubmission standards and writing requirements for medical authors
- General review inquiries: within 5–7 business days
- Correction reports: acknowledged within 48 hours, resolved within 5 business days
- Urgent safety concerns: response within 4 hours during business hours
- Reviewer applications: initial response within 5 business days
- Writing for DrInsight? Read the Author Guidelines before submitting
- All review standards are defined in our Editorial Policy